Dr. Schwartz discusses what the best A1c might be for a patient with diabetes, the current ADA guidelines, and how the guidelines have changed over the years taking into account different clinical data and criteria, including measurements of retinopathy and CV health. He also discusses the possibility of getting A1c’s even lower in the future, especially with better screening, prevention with lifestyle changes, and treating prediabetes.
More videos with Dr. Schwartz:
Stanley Schwartz, MD, Introduction
Preventing Hypoglycemia in the Hospital Using Incretins
Tips for Maximizing Medication Effectiveness and Patient Health
How Exercise Fits In with Diabetes Control
Stanley Schwartz, MD, has been awarded the honor of being a TOP DOC by Philadelphia Magazine many times over the years, including 2009, 2010 and 2011 for the treatment of diabetes and metabolic syndrome. For over 30 years, Dr. Schwartz was an Associate Professor at the University of Pennsylvania, most recently directing the Diabetes Program at the Philadelphia Heart Institute. Dr. Stanley Schwartz is a new Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.
Dr. Schwartz serves on the following Advisory Boards: Eli Lilly, Inc.; Amylin Pharmaceuticals; Takeda; Janssen; sanofi-aventis; and Santarus
He is also part of the following speaker’s bureaus: Merck; Eli Lilly; Amylin Pharmaceuticals; Takeda; Santarus; BMS; Astra-Zeneca; and Novo Novartis.
Diabetes In Control is honored to also have Dr. Schwartz on our Advisory Board as well as a contributor to our newsletters.